Supplementary Data from Multicenter Phase I/II Study of Nivolumab Combined with Paclitaxel Plus Ramucirumab as Second-line Treatment in Patients with Advanced Gastric Cancer
Authors:
- Takako Eguchi NakajimaTNTakako Eguchi Nakajima
- Shigenori KadowakiSKShigenori Kadowaki
- Keiko MinashiKMKeiko Minashi
- Tomohiro NishinaTNTomohiro Nishina
- Takeharu YamanakaTYTakeharu Yamanaka
- Yuichiro HayashiYHYuichiro Hayashi
- Naoki IzawaNINaoki Izawa
- Kei MuroKMKei Muro
- Shuichi HironakaSHShuichi Hironaka
- Takeshi KajiwaraTKTakeshi Kajiwara
- Yutaka KawakamiYKYutaka Kawakami
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)